linear peptide, pharmaceutical composition, method for treating a melanocortin receptor mediated disease, indication, condition or syndrome in a human or non-human mammal and method for treating a condition responsive to changes in melanocortin receptor function in a human or non-human mammal

摘要

Melanocortin receptor-specific linear peptides of the formula where R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined in the specification, compositions and formulations including peptides of the foregoing formula or salts thereof, and pharmaceutical compositions for preventing, ameliorating or treating melanocortin-1 receptor-mediated or responsive diseases, indications, conditions and syndromes.